Ahren Innovation Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Cambridge Epigenetixcambridge-epigenetix.cominApr 2018SEC filinghigh confidence
BiotechCambridge
Martin Murphy(Director)Jason Mellad(Executive Officer, Director)Bobby Yerramilli-Rao(Director)Somasundaram Subramaniam(Director)Timothy Rink(Director)Thomas Hulme(Director)
Board seatAlice Newcombe-EllisShankar Balasubramanian· per SEC Form D · $12.3M raise · filed May 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.